跳至主要内容
临床试验/NCT01033903
NCT01033903已完成不适用

Which is the Optimal Treatment for Miscarriage With a Gestational ac in the Uterus and Which Factors Can Predict if the Treatment Will be Successful?

Region Skane1 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2008年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Region Skane
入组人数
190
试验地点
1
主要终点
complete miscarriage

研究概览

简要总结

The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • nonviable intrauterine pregnancy with retained gestational sac in the uterus
  • the embryo if visible 5 to 35 mm without a heart beat
  • vaginal bleeding
  • circulatory stable
  • hemoglobin at least 80 g/L

排除标准

  • contraindications against misoprostol

研究组 & 干预措施

Misoprostol 800 micrograms intravaginally

Experimental

干预措施: misoprostol (Drug)

结局指标

主要结局

complete miscarriage

时间窗: 10 days

次要结局

  • complete miscarriage(17 days, 24 days, 31 days)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Optimal Treatment of Miscarriage | 临床试验